Analyses included 5,752 patients from BCAC cohorts, including cases not known to be BRCA1/2 carriers, and 107 breast cancer patients from one study of familial breast cancer patients with BRCA1/2 mutations (Table 1; Additional file 4: Table S2; Additional file 5: Figure S3). This evidence concerns the gene BRCA1 and breast carcinoma.